Thermo Fisher Scientific Inc.
TMO
$605.00
$5.310.89%
NYSE
| 06/27/2026 | 03/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 8.99% | -9.91% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 8.99% | -9.91% | |||
| Cost of Revenue | 7.97% | -8.51% | |||
| Gross Profit | 10.49% | -11.90% | |||
| SG&A Expenses | 7.44% | -4.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | 100.74% | |||
| Total Operating Expenses | 7.85% | -6.16% | |||
| Operating Income | 14.22% | -23.86% | |||
| Income Before Tax | 10.54% | -18.70% | |||
| Income Tax Expenses | 138.57% | -54.25% | |||
| Earnings from Continuing Operations | 5.13% | -15.94% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | 16.67% | |||
| Net Income | 5.15% | -15.94% | |||
| EBIT | 14.22% | -23.86% | |||
| EBITDA | 13.50% | -18.44% | |||
| EPS Basic | 5.43% | -15.03% | |||
| Normalized Basic EPS | 12.03% | -24.08% | |||
| EPS Diluted | 5.63% | -15.19% | |||
| Normalized Diluted EPS | 12.34% | -24.08% | |||
| Average Basic Shares Outstanding | -0.27% | -1.06% | |||
| Average Diluted Shares Outstanding | -0.54% | -1.06% | |||
| Dividend Per Share | 0.00% | 9.30% | |||
| Payout Ratio | 0.03% | 0.19% | |||